77 related articles for article (PubMed ID: 8690022)
1. E-cadherin expression and in vitro invasion of canine mammary tumor cells.
Spieker N; Mareel M; Bruyneel EA; Nederbragt H
Eur J Cell Biol; 1995 Dec; 68(4):427-36. PubMed ID: 8690022
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of the N-cadherin/catenin complex in retinoblastoma.
Van Aken EH; Papeleu P; De Potter P; Bruyneel E; Philippé J; Seregard S; Kvanta A; De Laey JJ; Mareel MM
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):595-602. PubMed ID: 11867572
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
[TBL] [Abstract][Full Text] [Related]
5. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.
Davies G; Jiang WG; Mason MD
Anticancer Res; 1999; 19(1A):547-52. PubMed ID: 10226596
[TBL] [Abstract][Full Text] [Related]
6. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
[TBL] [Abstract][Full Text] [Related]
7. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
Furbert-Harris PM; Parish-Gause D; Hunter KA; Vaughn TR; Howland C; Okomo-Awich J; Forrest K; Laniyan I; Abdelnaby A; Oredipe OA
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1009-16. PubMed ID: 14682382
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
[TBL] [Abstract][Full Text] [Related]
9. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-cadherin misexpression by the mammary epithelium in mice.
Knudsen KA; Sauer C; Johnson KR; Wheelock MJ
J Cell Biochem; 2005 Aug; 95(6):1093-107. PubMed ID: 15838877
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
[TBL] [Abstract][Full Text] [Related]
13. Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance.
Orecchia S; Schillaci F; Salvio M; Libener R; Betta PG
Lung Cancer; 2004 Aug; 45 Suppl 1():S37-43. PubMed ID: 15261432
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
[TBL] [Abstract][Full Text] [Related]
15. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Nowak M; Madej JA; Podhorska-Okolow M; Dziegiel P
In Vivo; 2008; 22(4):463-9. PubMed ID: 18712173
[TBL] [Abstract][Full Text] [Related]
16. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin.
Gaetje R; Kotzian S; Herrmann G; Baumann R; Starzinski-Powitz A
Am J Pathol; 1997 Feb; 150(2):461-7. PubMed ID: 9033262
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
[TBL] [Abstract][Full Text] [Related]
18. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
19. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
20. E-, P-, and N-cadherin are co-expressed in the nasopharyngeal carcinoma cell line TW-039.
Lou PJ; Chen WP; Lin CT; DePhilip RM; Wu JC
J Cell Biochem; 1999 Nov; 76(1):161-72. PubMed ID: 10581010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
